Interactions between dupilumab and vitiligo: A scoping review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interactions between dupilumab and vitiligo: A scoping review

Published:2024-08-06 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Mehta Shanti¹^ORCID,Metko Dea²^ORCID,Piguet Vincent³⁴

Affiliation:

1. Temerty Faculty of Medicine University of Toronto Toronto Ontario Canada

2. Michael G. DeGroote School of Medicine McMaster University Hamilton Ontario Canada

3. Division of Dermatology, Department of Medicine University of Toronto Toronto Ontario Canada

4. Division of Dermatology Women's College Hospital Toronto Ontario Canada

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20279

Reference5 articles.

1. Adverse events associated with dupilumab in the World Health Organization pharmacovigilance database;Bettuzzi T;J Am Acad Dermatol,2022

2. T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases

3. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

4. Vitiligo during dupilumab therapy

5. Vanishing vitiligo? Dupilumab and aeroallergen immunotherapy improve longstanding vitiligo;Miller M;Ann Allergy Asthma Immunol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP